Simulations Plus partnered with Nvidia to integrate GPU-powered computing into pharmaceutical simulation software. The collaboration targets quantitative systems pharmacology and pharmacokinetics workflows to increase processing speed and scale. This is an incremental step in digitizing drug development. Researchers can now run complex biological models with significantly lower latency.